Could 99mTc-glucarate be used to evaluate tumour necrosis? In vitro and in vivo studies in leukaemic tumour cell line U937

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 7, 2008, Pages 1290-1298

  Perek, Nathalie ^a   Sabido, Odile ^a   Le Jeune, Nathalie ^a   Prevot, Nathalie ^a   Vergnon, Jean Michel ^a   Clotagatide, Anthony ^a   Dubois, Francis ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

Author keywords

99mTc glucarate; Apoptosis; Flow cytometry; Leukaemic cell line; Necrosis

Indexed keywords

ETOPOSIDE; FLUORESCEIN; GLUTARATE TECHNETIUM TC 99M; GLUTARIC ACID DERIVATIVE; LIPOCORTIN 5; PROPIDIUM IODIDE; TECHNETIUM 99M; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SACCHARIC ACID; TECHNETIUM COMPLEX; TECHNETIUM TC 99M GLUCARATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL FRACTIONATION; CELL NUCLEUS; CELL SELECTION; CELL STRAIN U937; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; NUDE MOUSE; RADIOISOTOPE DIAGNOSIS; TREATMENT RESPONSE; TUMOR NECROSIS; XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; CELL SURVIVAL; LARGE CELL LYMPHOMA; NECROSIS; PATHOLOGY; SCINTISCANNING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL SURVIVAL; ETOPOSIDE; GLUCARIC ACID; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MICE; MICE, NUDE; NECROSIS; NEOPLASM TRANSPLANTATION; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TRANSPLANTATION, HETEROLOGOUS; U937 CELLS;

EID: 45049083059     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0689-6     Document Type: Article

References (34)

1. Arteaga de Murphy C, Ferro-Flores G, Villanueva-Sanchez O, Murphy-Stack E, Pedraza-Lopez M, Melendez-Alafort L, et al. 99mTc-glucarate for detection of isoproterenol-induced myocardial infarction in rats. Int J Pharm 2002;233:29-34.
2. Ballinger JR, Hsue V, Rauth AM. Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour models. Nucl Med Commun 2003;24:597-606.
3. Chung JK, Chang YS, Lee YJ, Kim YJ, Jeong JM, Lee DS, et al. The effect of tumor size on F-18-labeled fluorodeoxyglucose and fluoroerythronitroimidazole uptake in a murine sarcoma model. Ann Nucl Med 1999;13:303-8.
4. Demoy M, Minko T, Kopeckova P, Kopecek J. Time- and concentration- dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. J Control Release 2000;69:185-96.
5. Denoyer D, Perek N, Jeune NL, Frere D, Sabido O, Clotagatide A, et al. In vitro and in vivo evaluation of the influence of type III NaPi co-transporter activity during apoptosis on 99mTc-(V)DMSA uptake in the human leukaemic cell line U937. Eur J Nucl Med Mol Imaging 2004;31:1421-7.
6. Flotats A, Carrio I. Non-invasive in vivo imaging of myocardial apoptosis and necrosis. Eur J Nucl Med Mol Imaging 2003;30:615-30.
7. Imam SK. Molecular nuclear imaging: the radiopharmaceuticals (review). Cancer Biother Radiopharm 2005;20:163-72.
8. Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther 2005;4:139-63.
9. Kartachova M, Haas RL, Olmos RA, Hoebers FJ, van Zandwijk N, Verheij M. In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response. Radiother Oncol 2004;72:333-9.
10. Keen HG, Dekker BA, Disley L, Hastings D, Lyons S, Reader AJ, et al. Imaging apoptosis in vivo using 124I-annexin V and PET. Nucl Med Biol 2005;32:395-402.
11. Khaw BA, Nakazawa A, O'Donnell SM, Pak KY, Narula J. Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. J Nucl Cardiol 1997;4:283-90.
12. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84:1415-20.
13. Kuge Y, Sato M, Zhao S, Takei T, Nakada K, Seki KI, et al. Feasibility of 99mTc-annexin V for repetitive detection of apoptotic tumor response to chemotherapy: an experimental study using a rat tumor model. J Nucl Med 2004;45:309-12.
14. Liu Z, Stevenson GD, Barrett HH, Kastis GA, Bettan M, Furenlid LR, et al. 99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice. Nucl Med Commun 2004;25:711-20.
15. Mochizuki T, Kuge Y, Zhao S, Tsukamoto E, Hosokawa M, Strauss HW, et al. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V. J Nucl Med 2003;44:92-7.
16. Murakami Y, Takamatsu H, Taki J, Tatsumi M, Noda A, Ichise R, et al. 18F-labelled annexin V: a PET tracer for apoptosis imaging. Eur J Nucl Med Mol Imaging 2004;31:469-74.
17. Naito M, Shiina K, Mashima T, Nagashima K, Tsuruo T. Induction of in vitro nuclear apoptosis activity coincides with the production of 50 kDa cytosolic protein. Cell Death Differ 1997;4:617-22.
18. Narula J, Petrov A, Pak KY, Lister BC, Khaw BA. Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with 99mTc-labeled glucarate. Circulation 1997;95:1577-84.
19. Okada DR, Johnson G 3rd, Liu Z, Hocherman SD, Khaw BA, Pak KY, et al. Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia. J Nucl Cardiol 2003;10:168-76.
20. Pak KY, Nedelman MA, Tam SH, Wilson E, Daddona PE. Labeling and stability of radiolabeled antibody fragments by a direct 99mTc-labeling method. Int J Radiat Appl Instrum B Nucl Med Biol 1992;19:669-77.
21. Peng L, Jiang H, Bradley C. Annexin V for flow cytometric detection of phosphatidylserine expression on lymphoma cells undergoing apoptosis. Hua Xi Yi Ke Da Xue Xue Bao 2001;32:602-4, 620.
22. Pepper C, Thomas A, Tucker H, Hoy T, Bentley P. Flow cytometric assessment of three different methods for the measurement of in vitro apoptosis. Leuk Res 1998;22:439-44.
23. Petrov AD, Narula J, Nakazawa A, Pak KY, Khaw BA. Targeting human breast tumour in xeno-grafted SCID mice with 99Tcm-glucarate. Nucl Med Commun 1997;18:241-51.
24. Proskuryakov SY, Konoplyannikov AG, Gabai VL. Necrosis: a specific form of programmed cell death. Exp Cell Res 2003;283:1-16.
25. Schimming R, Mason KA, Hunter N, Weil M, Kishi K, Milas L. Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel. Cancer Chemother Pharmacol 1999;43:165-72.
26. Schultz DR, Harrington WJ Jr. Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum 2003;32:345-69.
27. Spaepen K, Stroobants S, Dupont P, Bormans G, Balzarini J, Verhoef G, et al. [(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction. Eur J Nucl Med Mol Imaging 2003;30:682-8.
28. Takei T, Kuge Y, Zhao S, Sato M, Strauss HW, Blankenberg FG, et al. Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation. J Nucl Med 2005;46:794-9.
29. Tannock IF, Lee C. Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs. Br J Cancer 2001;84:100-5.
30. Vermes I, Haanen C, Richel DJ, Schaafsma MR, Kalsbeek-Batenburg E, Reutelingsperger CP. Apoptosis and secondary necrosis of lymphocytes in culture. Acta Haematol 1997;98:8-13.
31. Wu RC, Chen DF, Liu MJ, Wang Z. Dual effects of cycloheximide on U937 apoptosis induced by its combination with VP-16. Biol Pharm Bull 2004;27:1075-80.
32. Yagle KJ, Eary JF, Tait JF, Grierson JR, Link JM, Lewellen B, et al. Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J Nucl Med 2005;46:658-66.
33. Yaoita H, Fischman AJ, Wilkinson R, Khaw BA, Juweid M, Strauss HW. Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium. J Nucl Med 1993;34:1303-8.
34. Yaoita H, Uehara T, Brownell AL, Rabito CA, Ahmad M, Khaw BA, et al. Localization of technetium-99m-glucarate in zones of acute cerebral injury. J Nucl Med 1991;32:272-8.